AETHLON MEDICAL INC

Although these proxy materials are being mailed to stockholders, copies of this Proxy Statement and our Annual Report on Form 10-K for the fiscal year ended March 31, 2026 will also be available on or about September 1, 2026 at https://www.aethlonmedical.com/investors/sec-filings.

Only stockholders of record at the close of business on August 10, 2026 (the “Record Date”) are entitled to notice of, and to vote at, the Annual Meeting.

We have selected James B. Frakes and Edward G. Broenniman, and each of them individually, to serve as the proxy holders for the Annual Meeting. Shares of common stock represented by each properly executed and returned proxy, or otherwise validly submitted proxy, will be voted by Mr. Frakes and/or Mr. Broenniman, as applicable, in accordance with the instructions indicated therein. If you sign and return your proxy card, or otherwise submit your proxy, without giving specific voting instructions, your shares will be voted “FOR” the election of each of the director nominees named in this Proxy Statement, “FOR” Proposals 2, 3, 4, 6, 7, 8, 9 and 10. The proxy also confers discretionary authority to vote the shares represented thereby on any other matter that may properly come before the Annual Meeting or any adjournment or postponement thereof. As of the date of this Proxy Statement, we know of no other matters to be presented for action at the Annual Meeting.